Yu CAO
About Yu CAO
Yu Cao is a Senior Scientist at Tessera Therapeutics, where he leads the development of models and conducts evaluations for gene and cell therapy studies. With over 15 years of experience in biology and medicine, he specializes in genetic engineering and immuno-oncology.
Work at Tessera Therapeutics
As a Senior Scientist at Tessera Therapeutics since 2022, responsibilities include leading the establishment of models and conducting in vivo and ex vivo evaluations for proof of concept studies in gene and cell therapy development. The role emphasizes the development of novel gene and cell therapies through gene writing and rewriting modalities, contributing to advancements in the field.
Education and Expertise
Yu Cao holds a Master of Science in Infection and Immunity from the University of Sydney. Additionally, Cao earned a Doctor of Philosophy in Biochemistry and Molecular Biology from the Academy of Military Medical Sciences. A Bachelor of Science in Biotechnology was obtained from Sichuan University. This educational background supports expertise in genetic engineering and immuno-oncology.
Background
Prior to joining Tessera Therapeutics, Yu Cao worked as a Research Scientist at Moffitt Cancer Center from 2017 to 2020. This position was based in the Tampa/St. Petersburg, Florida area. Before that, Cao served as a Postdoctoral Researcher at Augusta University from 2014 to 2017 in the Augusta, Georgia area. These roles contributed to over 15 years of experience in the biology and medicine field, with a focus on cancer therapeutics.
Achievements
Yu Cao has developed strong skills in genetic engineering and communication within the field of immuno-oncology. The expertise gained through various research positions and educational experiences has positioned Cao as a knowledgeable professional in gene and cell therapy development.